BioCryst Pharmaceuticals, Inc. Common Stock (NASDAQ: BCRX) last traded at $8.36, down 2.22% on the session. The quote above updates while this page is open; the figures below are drawn from BioCryst Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
BioCryst Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker BCRX. Its market capitalisation is $2.14 billion.
Valuation measures for BioCryst Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.14B |
|---|---|
| Enterprise value | $2.99B |
| Price / sales | 2.27 |
| Beta | 0.67 |
Trailing-twelve-month figures tagged in BioCryst Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $940.61M |
| Net income (TTM) | -$384.67M |
|---|
| EPS (TTM) | -$1.49 |
|---|
| Gross margin | 97.78% |
|---|
| Operating margin | -33.29% |
|---|
| Cash | $154.97M |
|---|
Range and volume for BCRX over the past 52 weeks.
| 52-week high | $11.22 |
|---|---|
| 52-week low | $6.00 |
| Volume | 3.46M |
| Average volume | 4.10M |
| Previous close | $8.55 |
Invest a chosen dollar amount in BioCryst Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BCRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.